Literature DB >> 9014638

Tolerance of laparoscopy for resection of phaeochromocytoma.

C Mann1, B Millat, G Boccara, J Atger, P Colson.   

Abstract

We describe two patients who underwent resection of phaeochromocytoma by a laparoscopic approach. Although outcome from surgery was successful, there was marked variability in hormonal and haemodynamic changes. In one patient, despite an infusion of nicardipine, peritoneal insufflation produced a marked increase in catecholamine concentrations associated with transient but intense vasoconstriction, but there was no change in the second patient. In both patients, exsufflation caused no significant haemodynamic changes in spite of the high doses of nicardipine given throughout the procedures.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9014638     DOI: 10.1093/bja/77.6.795

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  4 in total

1.  [Minimally invasive adrenalectomy for pheochromocytoma: routine or risk?].

Authors:  I Gockel; A Heintz; W Roth; T Junginger
Journal:  Chirurg       Date:  2006-01       Impact factor: 0.955

2.  Endoscopic adrenalectomy for pheochromocytoma: difference between the transperitoneal and retroperitoneal approaches in terms of the operative course.

Authors:  I Gockel; G Vetter; A Heintz; Th Junginger
Journal:  Surg Endosc       Date:  2005-05-26       Impact factor: 4.584

3.  Safe retroperitoneal endoscopic resection of pheochromocytomas.

Authors:  Frits J Berends; Erwin Van Der Harst; Giuseppe Giraudo; Türkan Terkivatan; Geert Kazemier; Hajo A Bruining; Wouter W De Herder; H Jaap Bonjer
Journal:  World J Surg       Date:  2002-03-01       Impact factor: 3.352

4.  Laparoscopic adrenalectomy for pheochromocytoma is more difficult compared to other adrenal tumors.

Authors:  Michał Natkaniec; Michał Pędziwiatr; Mateusz Wierdak; Magdalena Białas; Piotr Major; Maciej Matłok; Piotr Budzyński; Jadwiga Dworak; Monika Buziak-Bereza; Andrzej Budzyński
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2015-07-06       Impact factor: 1.195

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.